Compare MOVE & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MOVE | BLFS |
|---|---|---|
| Founded | 2018 | 1987 |
| Country | United States | United States |
| Employees | 32 | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 901.4M | 923.5M |
| IPO Year | 2021 | 2013 |
| Metric | MOVE | BLFS |
|---|---|---|
| Price | $18.77 | $18.52 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $32.00 |
| AVG Volume (30 Days) | 29.0K | ★ 494.2K |
| Earning Date | 04-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 77.27 |
| EPS | N/A | ★ N/A |
| Revenue | $1,013,000.00 | ★ $96,214,000.00 |
| Revenue This Year | $1,460.71 | $19.73 |
| Revenue Next Year | $96.77 | $17.82 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 16.97 |
| 52 Week Low | $0.51 | $17.86 |
| 52 Week High | $34.87 | $29.57 |
| Indicator | MOVE | BLFS |
|---|---|---|
| Relative Strength Index (RSI) | 71.16 | 37.55 |
| Support Level | $6.27 | $17.86 |
| Resistance Level | $21.23 | $26.77 |
| Average True Range (ATR) | 1.80 | 0.84 |
| MACD | 0.27 | 0.12 |
| Stochastic Oscillator | 83.60 | 25.10 |
Corvex Inc is an AI cloud computing company specializing in GPU accelerated infrastructure for AI workloads. The company provides AI-focused computing infrastructure that offers scalable computational resources. Its platform uses GPU-accelerated compute clusters and high-throughput storage to support performance, security, and efficiency at scale. The company's product portfolio includes GPU Clusters, Inference-as-a-Service, Confidential Computing, and GPU Node.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.